mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0006 |
mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0007 |
mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0008 |
mRNA |
GSK690693 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.0009 |
mRNA |
ciclosporin |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0009 |
mRNA |
AZ628 |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
0.0009 |
mRNA |
Pyrimethamine |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
0.001 |
mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
masitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.001 |